Works by Trafalis, Dimitrios T.


Results: 40
    1
    2
    3
    4
    5
    6

    Cytocidal Antitumor Effects against Human Ovarian Cancer Cells Induced by B-Lactam Steroid Alkylators with Targeted Activity against Poly (ADP-Ribose) Polymerase (PARP) Enzymes in a Cell-Free Assay.

    Published in:
    Biomedicines, 2021, v. 9, n. 8, p. 1028, doi. 10.3390/biomedicines9081028
    By:
    • Nikoleousakos, Nikolaos;
    • Dalezis, Panagiotis;
    • Polonifi, Aikaterini;
    • Geromichalou, Elena G.;
    • Sagredou, Sofia;
    • Alifieris, Constantinos E.;
    • Deligiorgi, Maria V.;
    • Sarli, Vasiliki;
    • Trafalis, Dimitrios T.
    Publication type:
    Article
    7
    8
    9
    10
    11
    12
    13
    14

    Isothiocyanates Potentiate Tazemetostat-Induced Apoptosis by Modulating the Expression of Apoptotic Genes, Members of Polycomb Repressive Complex 2, and Levels of Tri-Methylating Lysine 27 at Histone 3 in Human Malignant Melanoma Cells.

    Published in:
    International Journal of Molecular Sciences, 2024, v. 25, n. 5, p. 2745, doi. 10.3390/ijms25052745
    By:
    • Anestopoulos, Ioannis;
    • Paraskevaidis, Ioannis;
    • Kyriakou, Sotiris;
    • Giova, Lambrini E.;
    • Trafalis, Dimitrios T.;
    • Botaitis, Sotiris;
    • Franco, Rodrigo;
    • Pappa, Aglaia;
    • Panayiotidis, Mihalis I.
    Publication type:
    Article
    15
    16
    17
    18
    19
    20

    Isothiocyanates Enhance the Anti-Melanoma Effect of Zebularine Through Modulation of Apoptosis and Regulation of DNMTs' Expression, Chromatin Configuration and Histone Posttranslational Modifications Associated with Altered Gene Expression Patterns.

    Published in:
    Epigenomes, 2025, v. 9, n. 1, p. 7, doi. 10.3390/epigenomes9010007
    By:
    • Anestopoulos, Ioannis;
    • Paraskevaidis, Ioannis;
    • Kyriakou, Sotiris;
    • Potamiti, Louiza;
    • Trafalis, Dimitrios T.;
    • Botaitis, Sotiris;
    • Franco, Rodrigo;
    • Pappa, Aglaia;
    • Panayiotidis, Mihalis I.
    Publication type:
    Article
    21
    22
    23
    24
    25
    26
    27
    28
    29
    30
    31
    32
    33
    34
    35
    36

    Efficacy and Safety of Neoadjuvant Treatment with Bevacizumab, Liposomal Doxorubicin, Cyclophosphamide and Paclitaxel Combination in Locally/Regionally Advanced, HER2-Negative, Grade III at Premenopausal Status Breast Cancer: A Phase II Study.

    Published in:
    Clinical Drug Investigation, 2018, v. 38, n. 7, p. 639, doi. 10.1007/s40261-018-0655-z
    By:
    • Tampaki, Ekaterini C.;
    • Tampakis, Athanasios;
    • Alifieris, Constantinos E.;
    • Krikelis, Dimitrios;
    • Pazaiti, Anastasia;
    • Kontos, Michalis;
    • Trafalis, Dimitrios T.
    Publication type:
    Article
    37
    38
    39
    40